Generic Famvir is used for treating herpes zoster infection (shingles). It is also used to treat recurring herpes skin infections in patients who also have HIV infection. Famvir is used in patients who have a weakened immune system to treat recurring cold sores and to treat or suppress recurring genital herpes. More info »
Generic Relenza is used to treat flu symptoms caused by influenza virus in patients who have had symptoms for less than 2 days. It may also be given to prevent influenza in people who may be exposed but do not yet have symptoms. It will not treat the common cold. More info »
Generic Valtrex is used for treating shingles (herpes zoster), cold sores (fever blisters or herpes labialis), and treating or suppressing genital herpes in patients with normal immune systems. It is also used to suppress genital herpes in patients with HIV infection. More info »
Good Morning:
The generic V is as expected, makes a good
thing better, and the price is such that it
is used all the time. Eliminates performance
anxiety !
Thank you for your help.
- Sincerely, Steve
Public weighs in on pandemic antiviral distribution - CIDRAP
Public weighs in on pandemic antiviral distributionCIDRAPMay 18, 2012 (CIDRAP News) – The Institute of Medicine (IOM) yesterday shared findings of three public opinion panels on antiviral distribution during a flu pandemic, including a nod for establishing diverse alternative strategies and support for Web .
Antiviral research and Neutron Star System behaviours earn BC students ... - Canada NewsWire (press release)
Antiviral research and Neutron Star System behaviours earn BC students .
Broad-Spectrum Antivirals: The Future of HIV Treatment? - TheBody.com
Broad-Spectrum Antivirals: The Future of HIV Treatment?TheBody.
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... - MarketWatch (press release)
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs .
New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation.